Table 5.

Factors associated with following fewer of the ‘Smarter Medicine’ Top five recommendations (n = 159) ^a .

Characteristic	Univariate incidence rate ratio (95%CI) b	P	Multivariate incidence rate ratio (95%CI) b	P
Sex (women)	0.98 (0.77–1.25)	0.86	–
Age, years	1.00 (0.99–1.01)	0.91	–
Language area, German	0.75 (0.62–0.92)	0.01	1.05 (0.84–1.30)	0.69
Country of medical training, outside Switzerland	1.08 (0.73–1.61)	0.69	–
Experience in practice, years	1.00 (0.99–1.01)	0.90	–
Practice size, five or more physicians	0.82 (0.56–1.19)	0.30	–
Practice location, rural	1.01 (0.81–1.26)	0.91	–
In-practice pharmacy, yes	0.70 (0.57–0.86)	<0.01	0.71 (0.57–0.88)	0.002
In-practice laboratory, yes	0.94 (0.66–1.35)	0.74	–
In-practice radiology, yes	0.93 (0.75–1.16)	0.53	–
Knows of ‘Smarter Medicine’	0.91 (0.73–1.14)	0.42	–	–
Mean agreement with recommendations ≤8 c	1.62 (1.34–1.96)	<0.01	1.60 (1.33–1.94)	<0.001

^aDefined as responding ‘nearly always’ for discussing prostate cancer screening prior to testing and ‘rarely or never’ to the other four clinical scenarios.

^bIncidence rate ratio gives the ratio for following one additional recommendation.

^cMean agreement for individual GPs with the five recommendation statements.